FDA's new AI and wearables guidance - McDermott+

FDA’s new AI and wearables guidance

This week in the Breakroom, Paul Gadiock, Partner at McDermott Will and Schulte, joins Erin Fuller to discuss the recent FDA guidance on clinical decision support (CDS) software and general wellness products, and the tone this sets for the future of digital health product regulation.

Read more about the new guidance in our client alert.